Blogs
In recent years, cancer research and treatment centers have been awash with a wave of new, exciting developments, under the umbrella of “immunotherapy, ”...
Hi, what are you looking for?
Jewish Business News
Business
– We plan to make investments by the end of the year, says Tsing Capital’s Don Ye. – “Cleantech is probably the most...
IPOs
– BiondVax is exploring two options – either a conventional offering or listing American Depositary Receipts. – Universal flu vaccine developer BiondVax Pharmaceuticals...
IPOs
– The Israeli Parkinson’s disease treatment developer is seeking $58-72 million at a company value of $290 million. – Rehovot-based NeuroDerm, which has...
Business
– The Opko Health Chairman hopes to attain a value of over $100 million for the Rehovot-based vaccination developer. Vaccination company SciGen, controlled...
Business
– The project brings together a consortium of parties from Israel, Jordan, and Switzerland for the treatment of the parasitic disease. – Researchers from...
Business
– Smallcap investor network report: An experimental Ebola drug can be produced on Protalix‘s vegetable platform. Anxiety about the Ebola disease increased again at...
IPOs
– After the fiasco of the failed IPO in August, the drug development company scaled down the offering. VBL Therapeutics has raised $40 million...
Business
– Investor Mori Arkin: If Hyperion overlooked weak points in the data, it’s their mistake. – The Andromeda affair, in which an Israeli company...
Leadership
– The donation will fund drug development, computer science, cyber research, movie production and more. – The Blavatnik Family Foundation is donating $20...